Apomine, an inhibitor of HMG-CoA-reductase, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of myeloma in vivo.
Apomine, a novel 1,1 bisphosphonate ester, increases the rate of degradation of HMG-CoA reductase, inhibiting the mevalonate pathway and thereby blocking cholesterol biosynthesis. We have investigated whether Apomine can induce myeloma cell apoptosis in vitro and modulate myeloma disease in vivo. Ap...
Main Authors: | Edwards, C, Mueller, G, Roelofs, A, Chantry, A, Perry, M, Russell, R, Van Camp, B, Guyon-Gellin, Y, Niesor, E, Bentzen, C, Vanderkerken, K, Croucher, P |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
2007
|
פריטים דומים
-
Apomine, an inhibitor of HMG-COA-reductase, does not act by inhibiting protein prenylation in human myeloma cells in vitro
מאת: Roelofs, A, et al.
יצא לאור: (2005) -
APOMINE (TM), a novel inhibitor of the meyalonate/isoprenoid pathway, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of the myeloma disease in vivo.
מאת: Croucher, P, et al.
יצא לאור: (2002) -
Apomine enhances the antitumor effects of lovastatin on myeloma cells by down-regulating 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
מאת: Roelofs, A, et al.
יצא לאור: (2007) -
Novel insights into the anti-tumour mechanism of action of apomine and its synergistic interaction with lovastatin in myeloma cells in vitro
מאת: Roelofs, A, et al.
יצא לאור: (2006) -
Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease.
מאת: Croucher, P, et al.
יצא לאור: (2003)